Karuturi, M., Younes, A., Fayad, L., Kwak, L., Pro, B., Shah, J., . . . Fanale, M. (2015). ICE (ifosfamide, carboplatin, etoposide) with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma: Results of a randomized phase II trial. Leuk Lymphoma.
Citação norma ChicagoKaruturi, Meghan, et al. "ICE (ifosfamide, Carboplatin, Etoposide) With or Without Bortezomib in Patients With Relapsed/refractory Hodgkin Lymphoma: Results of a Randomized Phase II Trial." Leuk Lymphoma 2015.
Citação norma MLAKaruturi, Meghan, et al. "ICE (ifosfamide, Carboplatin, Etoposide) With or Without Bortezomib in Patients With Relapsed/refractory Hodgkin Lymphoma: Results of a Randomized Phase II Trial." Leuk Lymphoma 2015.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.